Company: CRVO
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001437749-25-007829
Chunk: 32

Company: CervoMed Inc.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 32
---
 of whom have worked on neflamapimod in the past at Vertex and are well acquainted with the unique properties of the compound for application in DLB and other potential target indications.

  Our Co-Founder, President and Chief Executive Officer, John Alam, MD, is a biotech industry veteran with more than 30 years’ experience and is an industry leader in translational medicine. He h...  

  Our Co-Founder and Director, Dr. Sylvie Gr é goire, PharmD., is also an industry veteran with more than 30 years’ experience who previously held executive leadership posts in several multinatio...  

  The Chair of our Board, Joshua S. Boger, PhD, is an industry veteran who has served in multiple scientific and business leadership roles during his multi-decade career. Dr. Boger founded Vertex...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Our Chief Operating Officer, Robert J. Cobuzzi, Jr., PhD, has over 25 years of cross-functional executive and operational leadership experience in the pharmaceutical and biotechnology industrie...  

  Our SVP of Clinical Development, Kelly Blackburn, MHA, has more than 30 years of experience in clinical development operations, including senior management positions at aTyr Pharma and Vertex w...  

  In addition, to provide a strong scientific underpinning for the neflamapimod program, we have surrounded ourselves with thought leaders in the fields of cell biology, intracellular signal tran...  

Our Directors

The table below sets forth, as of March 15, 2025, certain information concerning our current directors.

  Name                                 Age      Director Since  
 ────────────────────────────────────────────────────────────────
  Joshua S. Boger, Ph. D. (Chair)       73                2024  
  John Alam, M. D.                      63                2023  
  Robert J. Cobuzzi, Jr., Ph. D.        60                2023  
  Sylvie Grégoire, PharmD.              63                2023  
  Jane Hollingsworth, J. D.             66                2020  
  Jeff Poulton                          57                2023  
  Marwan Sabbagh, M. D.                 59                2023  
  Frank Zavrl                           59                2023  

38

Our